16 studies found for:    99mTc-DTPA
Show Display Options
Rank Status Study
1 Recruiting Early Screening and Diagnosis of CKD
Conditions: Kidney; Disease (Functional);   Chronic Kidney Disease
Intervention: Radiation: 99mTc-DTPA
2 Not yet recruiting Myocardial Flow Reserve and 99mTc-DTPA Cardiac Dynamic SPECT
Condition: Coronary Artery Disease
Intervention: Other: Cardiac SPECT
3 Unknown  The Efficacy of Color-Doppler Ultrasonography to Assess the Renal Blood Flow With the Estimation of GFR
Conditions: Hypertension;   Renal Failure
Intervention: Procedure: Color-Doppler Ultrasound, 99mTc-DTPA scintigraphy
4 Recruiting SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
Conditions: Lung Carcinoma;   Malignant Neoplasm
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
5 Not yet recruiting Gastric Emptying: in Vivo Studies in Healthy Volunteers
Condition: Gastric Disease
Intervention: Radiation: Gastric emptying scintigraphy using 99mTc-DTPA
6 Completed Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device
Condition: Healthy Subjects
Intervention: Drug: Ketorolac tromethamine
7 Recruiting Analysis of Deposition With Nebulizers Membrane
Condition: Healthy Volunteers
Interventions: Device: phase 1 - jet nebulizer;   Device: Phase 2- mesh nebulizer
8 Completed A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides
Condition: HIV Infections
Interventions: Drug: Normosol-R;   Drug: Nonoxynol-9;   Procedure: Gastrointestinal instrumentation
9 Terminated Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy
Condition: Glioblastoma Multiforme
Interventions: Drug: Neuradiab + Radiotherapy + Temozolomide;   Drug: Radiation Therapy + Temozolomide
10 Unknown  Medical and Endovascular Treatment of Atherosclerotic Renal Artery Stenosis (METRAS Study)
Condition: Renal Artery Stenosis
Interventions: Drug: Optimal medical therapy;   Procedure: revascularization
11 Completed Scintigraphic Assessment Following Klean-Prep® or Moviprep®
Conditions: Gastric Emptying;   Healthy
Interventions: Drug: Klean-Prep®;   Drug: Moviprep®
12 Recruiting FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
Conditions: Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Procedure: Computed Tomography;   Radiation: Fludeoxyglucose F-18;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography;   Radiation: Radiation Therapy;   Procedure: Single Photon Emission Computed Tomography;   Radiation: Technetium Tc-99m Albumin Aggregated;   Drug: Technetium Tc-99m DTPA
13 Recruiting Evaluation of Lung Deposition of Aerosol Via HFNC in Healthy Adults
Condition: Healthy
Interventions: Other: 10l/min;   Other: 30l/min;   Other: 50l/min
14 Completed Radioaerossol Pulmonary Deposition Using Mesh in Normal Subjects
Condition: Normal Subjects
Interventions: Other: Mesh nebulizer;   Other: Jet nebulizer;   Other: Noninvasive ventilation-NIV
15 Completed Tomographic Comparison of Aerosol Lung Distribution With Two Nebulizers Through a High Flow Nasal Cannula
Condition: Healthy
Interventions: Drug: Technetium-99m - Diethylenetriaminepentaacetic acid;   Device: Aeroneb Solo;   Device: Jet Nebulizer;   Other: Single photon emission computed tomography;   Other: Spirometry
16 Recruiting Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus;   Obese;   Overweight
Interventions: Radiation: Gastric Emptying test;   Other: Mixed Oral Glucose Tolerance test;   Drug: Conjugated bile acids sodium;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.